Device Trial Radar · NCT05777759
Safety and Effectiveness of Restylane Lyft With Lidocaine for Augmentation of the Chin Region to Improve the Chin Profile
Last checked: Nov 20, 2026Latest source record: May 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
175
Actual
Start
Mar 22, 2023
Primary completion
Nov 11, 2023
Study completion Jul 10, 2024
Sponsor
- Lead sponsor
- Galderma R&DNot on our public-company list
- Sponsor type
- Industry
- First posted
- Mar 21, 2023
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 22 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The primary objective of the study was to demonstrate non-inferiority of Restylane Lyft with Lidocaine versus a comparator-control for augmentation of the chin region to improve the chin profile.
Conditions
- Chin Augmentation
- Chin Retrusion
Interventions
Restylane Lyft with LidocaineDevice
hyaluronic acid
Juvederm Voluma XCDevice
hyaluronic acid
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in the Blinded Evaluators' Live Assessment Using the Galderma Chin Retrusion Scale (GCRS) at Month 3Time frame: Baseline (last non-missing observation prior to the first administration of study product) and Month 3
Locations
12 sites in 2 countries. Site status is shown where the registry gives one.
Galderma Research Site
Los Angeles, California
11 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.